Skip to main content
Pingxian Liu on Muck Rack

Pingxian Liu

As seen in: ACS Publications
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Pingxian

Contact Pingxian, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Advancing Tumor-Targeted Chemo-Immunotherapy: Development of the CAR-M-derived Exosome-Drug Conjugate

|
By Yunhan Jiang, Xiaoqiu Xu, Dongmei Fan, Pingxian Liu
| dx.doi.org
Open in Who Shared Issue with article?

Advancing Tumor-Targeted Chemo-Immunotherapy: Development of the CAR-M-derived Exosome-Drug Conjugate

|
By Yunhan Jiang, Xiaoqiu Xu, Dongmei Fan, Pingxian Liu
| ACS Publications
Open in Who Shared Issue with article?

Strategies for the Discovery of Oxazolidinone Antibacterial Agents: Development and Future Perspectives

|
By Pingxian Liu, Yunhan Jiang, Ling Jiao, Youfu Luo
| dx.doi.org
Oxazolidinones represent a significant class of synthetic bacterial protein synthesis inhibitors that are primarily effective against Gram-positive bacteria. The commercial success of linezolid, the first FDA-approved oxazolidinone antibiotic, has motivated researchers to develop more potent oxazolidinones by employing various drug development strategies to fight against antimicrobial resistance, some of which have shown promising results.
Open in Who Shared Issue with article?
See all 4 articles